Osteoporosis Prevention in Menopause: Your DEXA Scan Action Plan

Menopause causes rapid bone loss because estrogen is the body's most powerful brake on bone breakdown. Bone is living tissue that's constantly being broken down (resorption) and rebuilt (formation). Estrogen suppresses the activity of osteoclasts, the cells that break bone down. When estrogen drops sharply during the menopause transition, osteoclast activity surges, and bone is broken down faster than it can be rebuilt.

The Study of Women's Health Across the Nation (SWAN) — one of the largest longitudinal studies of menopause — found that women lose an average of 10% of spinal bone density and 9% of hip bone density in the 5-7 years surrounding the final menstrual period (Greendale GA, J Clin Endocrinol Metab 2012). The fastest loss happens in the year before and two years after menopause, with annual losses of 2-3% at the spine and 1-2% at the hip.

This matters because bone density predicts fracture risk. A woman who enters menopause with average bone density and loses 10% during the transition has measurably higher fracture risk for the rest of her life. By age 75, one in three women will have experienced an osteoporotic fracture (International Osteoporosis Foundation). Hip fractures in particular carry a 20-30% one-year mortality rate in older women — bone health isn't a vanity concern.

The standard recommendation is age 65 for all women, but most menopause specialists now advocate earlier scanning for women with risk factors. A DEXA (dual-energy X-ray absorptiometry) scan is the gold-standard test for bone density. It's quick (10-15 minutes), low-radiation, and widely covered by insurance when medically indicated.

Consider an earlier baseline scan (typically age 50-55) if you have any of: family history of osteoporosis or hip fracture; personal history of low-trauma fractures after age 45; early menopause (before age 45) or surgical menopause without HRT; BMI under 19; long-term use of glucocorticoids, proton pump inhibitors, or some antidepressants; thyroid disease; celiac or other malabsorption conditions; smoking history; heavy alcohol use; or being on a GLP-1 medication during the menopause transition (the combined risk warrants closer monitoring).

A baseline scan during perimenopause gives you a measurable starting point. Without it, you're guessing about your trajectory — you can't know if interventions are working without knowing where you began. Our article on [bone density loss with GLP-1s and menopause](/blog/bone-density-loss-glp-1-and-menopause-the-double-risk) explains why this matters even more for women managing both.

Your DEXA report shows two key numbers: a T-score and a Z-score. Most clinical decisions are based on the T-score, which compares your bone density to that of a healthy 30-year-old of the same sex. The T-score is reported in standard deviations:

T-score interpretation: -1.0 or higher = normal bone density; -1.0 to -2.5 = osteopenia (low bone density, increased fracture risk); -2.5 or lower = osteoporosis (high fracture risk); -2.5 or lower with a history of fracture = severe osteoporosis.

The Z-score compares your bone density to that of someone your same age and sex. It's most useful in younger women (under 50) to identify whether something unusual is causing bone loss. A Z-score lower than -2.0 in a premenopausal woman warrants investigation for secondary causes.

DEXA also reports FRAX: your 10-year probability of a major osteoporotic fracture and hip fracture, calculated from your bone density plus risk factors. A 10-year major fracture risk of 20% or higher, or hip fracture risk of 3% or higher, generally triggers a recommendation for pharmacological treatment.

Resistance training is the single most effective non-pharmacological intervention for preserving and building bone density in midlife women. Bone responds to mechanical loading — when muscles pull on bones with sufficient force, osteoblasts (bone-building cells) are stimulated to lay down new bone matrix. Walking and cardio are not enough; the load isn't sufficient to trigger meaningful bone remodeling at the hip and spine.

A 2018 meta-analysis in Osteoporosis International found that high-intensity progressive resistance training increased lumbar spine bone density by 1-2% over 6-12 months in postmenopausal women — equivalent to reversing roughly a year of menopause-related loss. Studies like LIFTMOR (Watson SL, JBMR 2018) showed that even women already diagnosed with osteoporosis can safely perform heavy resistance training under supervision and gain measurable bone density.

The protocol that works: 2-3 sessions per week of compound lifts — squats, deadlifts, presses, rows — performed with progressive overload. Sets of 5-8 reps at 70-85% of your one-rep max are most osteogenic. Impact-based exercise like jumping or skipping (where appropriate and safe) adds further benefit at the hip. Our [resistance training for menopause](/blog/resistance-training-for-menopause-the-bone-density-protocol) piece walks through the specific protocol.

For postmenopausal women, the target is 1,000-1,200mg of calcium daily and 800-2,000 IU of vitamin D daily. Get calcium primarily from food when possible — dietary calcium is better absorbed and associated with fewer side effects than supplements. Good sources include dairy (1 cup milk = 300mg), fortified plant milks, leafy greens like collards and bok choy, sardines with bones, and tofu set with calcium sulfate.

If you can't reach 1,000mg from food, supplement the difference — typically 500-600mg, taken in two doses (calcium absorption maxes out around 500mg at a time). Calcium citrate is better absorbed than calcium carbonate, especially if you take it with food or on acid-suppressing medications.

Vitamin D is non-negotiable for calcium absorption. Many women in midlife are deficient, especially in northern latitudes or with limited sun exposure. Aim for a serum 25-hydroxyvitamin D level of at least 30 ng/mL (some experts prefer 40-60 ng/mL). Most adults need 800-2,000 IU daily; some need more if levels stay low. Our [calcium and vitamin D guide](/blog/calcium-vitamin-d-menopause-bone-health-guide) covers dosing nuances in detail.

Protein matters too — aim for 1.0-1.2g per kg body weight daily, distributed across meals. Bone is roughly 50% protein by volume; building or maintaining it requires adequate protein intake. Magnesium (300-400mg) and vitamin K2 also play supporting roles.

Hormone therapy is the most effective intervention for preventing menopause-related bone loss when started within 10 years of menopause. Multiple trials, including the Women's Health Initiative, demonstrated that estrogen therapy reduces hip fractures by 30-40% and vertebral fractures by 30-40% in women on therapy (Rossouw JE, JAMA 2002; WHI 30-year follow-up, JAMA 2024).

The timing matters. Starting HRT before age 60 or within 10 years of menopause provides the most benefit with the lowest risk profile. The bone benefits wane within 1-3 years of stopping therapy, so HRT works best as long-term protection rather than a short course.

For women who can't or won't use HRT, FDA-approved alternatives include: bisphosphonates (alendronate, risedronate, zoledronic acid) — first-line for established osteoporosis; denosumab (Prolia) — twice-yearly injection; raloxifene — selective estrogen receptor modulator; teriparatide and abaloparatide — anabolic agents that actually build bone; and romosozumab — newer dual-action option. Treatment choice depends on fracture risk level, kidney function, and individual preference.

Our [when to start HRT](/blog/when-to-start-hrt-timing-and-the-window-of-opportunity) article covers the timing window in depth.

Several lifestyle factors meaningfully accelerate or compound menopause-related bone loss. Smoking is the single biggest modifiable factor — it directly inhibits osteoblast function and reduces estrogen levels even on HRT. Heavy alcohol use (more than 1 drink daily) impairs both bone formation and calcium absorption. Chronic stress and elevated cortisol suppress bone formation and increase resorption.

Medications also contribute. Proton pump inhibitors (PPIs) taken long-term reduce calcium absorption and have been associated with increased fracture risk. Glucocorticoids are the most damaging class. Some SSRIs, anticonvulsants, and aromatase inhibitors also affect bone metabolism. If you're on any of these long-term, talk to your doctor about monitoring and protective strategies.

Rapid weight loss — whether from dieting, bariatric surgery, or GLP-1 medications — accelerates bone loss. For women on GLP-1 medications during the menopause transition, the compounded risk is significant and deserves a deliberate protection strategy: resistance training, protein, calcium, vitamin D, and bone density monitoring. Our [bone density on GLP-1 + menopause](/blog/bone-density-loss-glp-1-and-menopause-the-double-risk) covers this combination in depth.

If you're in perimenopause or early menopause and want to protect your bones, here's a sequenced action plan that's grounded in current evidence. Month 1: Get a baseline DEXA scan if you have any risk factors. Run a comprehensive blood panel including 25-OH vitamin D, calcium, magnesium, TSH, and PTH. Start 1,000mg calcium daily from food or supplements and 1,000-2,000 IU vitamin D.

Month 2-3: Begin a resistance training program 2x weekly. Start with bodyweight or light weights, focus on form, build progressively. Add protein to every meal to reach 1.0-1.2g/kg body weight daily.

Month 4-6: Increase resistance training to 3x weekly with progressive overload. Discuss HRT with a menopause specialist if you're within the 10-year window and don't have contraindications. Quit smoking if you smoke. Limit alcohol to less than 5 drinks/week.

Year 2: Repeat DEXA at 1-2 years post-baseline to assess your trajectory. Adjust strategy based on results — if T-scores are stable or improving, you're winning. If declining, consider medication.